Revelation Biosciences Stock Analysis

Revelation Stock Analysis Notes

The company recorded a loss per share of 4.77. Revelation Biosciences had not issued any dividends in recent years. Revelation Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of immunologic-based therapeutics and diagnostics for the prevention and treatment of disease. The company was founded in 2019 and is based in New York, New York. Revelation Biosciences is traded on NASDAQ Exchange in the United States. To find out more about Revelation Biosciences contact James Rolke at 650 800 3717 or learn more at https://www.revbiosciences.com.

Revelation Biosciences Investment Alerts

Revelation Biosciences Thematic Classifications

Revelation Profitablity

Management Efficiency

The company has return on total asset (ROA) of (0.5098) % which means that it has lost $0.5098 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (2.7002) %, meaning that it generated substantial loss on money invested by shareholders. Revelation Biosciences' management efficiency ratios could be used to measure how well Revelation Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.01 in 2024. Return On Capital Employed is likely to climb to -1.24 in 2024. At this time, Revelation Biosciences' Total Assets are fairly stable compared to the past year. Other Current Assets is likely to climb to about 198.9 K in 2024, whereas Non Current Assets Total are likely to drop slightly above 61.8 K in 2024.

Technical Drivers

As of the 25th of November, Revelation Biosciences holds the Risk Adjusted Performance of 8.0E-4, variance of 103.23, and Coefficient Of Variation of (9,132). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Revelation Biosciences, as well as the relationship between them. Please check Revelation Biosciences risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and kurtosis to decide if Revelation Biosciences is priced some-what accurately, providing market reflects its current price of 0.0123 per share. As Revelation Biosciences appears to be a penny stock we also advise to check out its jensen alpha numbers.

Revelation Biosciences Price Movement Analysis

Revelation Biosciences Predictive Daily Indicators

Revelation Biosciences Forecast Models

Revelation Biosciences' time-series forecasting models are one of many Revelation Biosciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Revelation Biosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Revelation Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Revelation shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Revelation Biosciences. By using and applying Revelation Stock analysis, traders can create a robust methodology for identifying Revelation entry and exit points for their positions.

When running Revelation Biosciences' price analysis, check to measure Revelation Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revelation Biosciences is operating at the current time. Most of Revelation Biosciences' value examination focuses on studying past and present price action to predict the probability of Revelation Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revelation Biosciences' price. Additionally, you may evaluate how the addition of Revelation Biosciences to your portfolios can decrease your overall portfolio volatility.